Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $2.05, $0.08 better than the analyst estimate of $1.97. Revenue for the quarter came in at $11.3 billion versus the consensus estimate of $11.49 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2023 EPS of $7.95-$8.25, versus the consensus of $8.04.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.